• Skip to main content
  • Skip to secondary menu
  • Skip to footer
Clinical Digital Resource Collaborative

Clinical Digital Resource Collaborative

Designed and developed in the North East and North Cumbria by local GPs

National Health Service
  • Home
  • About Us
  • The Team
  • Resources
    • Referral Forms
    • EMIS Resources
      • CDRC EMIS Access
      • Long Term Condition (LTC) Management
      • Impact and Investment Fund (IIF)
      • Medicine Management
        • Precision Monitoring
        • DMARDs and High Risk Drugs
        • Safe Prescribing of Opioids / Opiates
      • Specialties
        • Cancer Guide for EMIS
        • EMIS Cardiovascular Overview
          • Atrial Fibrillation Guide for EMIS
          • CDRC Precision CVD Prevention Template
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Guide for EMIS
          • Peripheral Arterial Disease EMIS Guide
        • Infection
          • Infections Guide for EMIS
          • Blood Borne Virus (BBV)
        • Neurology Guide for EMIS
        • Respiratory Overview
          • BeatAsthma+
    • SystmOne Resources
      • National Early Warning Score 2 (NEWS2) Guide for SystmOne
      • Getting Started
        • Getting Started – Access
        • Getting Started – How-To’s
      • SystmOne Administration
      • Contract Management
        • Impact and Investment Fund (IIF)
        • Vaccinations
      • Long Term Condition Management
        • Call/ Recall System
        • Recall Recovery System
        • Care Planning
      • Safeguarding System
        • Safeguarding Adults
        • Safeguarding At Risk of Harming Others
        • Safeguarding Family/Household Cause for Concern
        • Safeguarding Children
      • Medicine Management
        • Drugs Requiring Monitoring System
        • Safety & Reviews
        • Safe Prescribing of Opioids / Opiates
        • Safe Prescribing of NSAIDS
        • Safe Prescribing of Lithium
        • Safe Prescribing of Valproate
        • Safe Prescribing of Corticosteroids / Steroids
      • Specialties
        • Blood Borne Virus (BBV) Test Alert for SystmOne
        • BeatAsthma+ Guide for SystmOne
        • Cancer Overview
          • Cancer
          • Suspected Cancer
        • Cardiovascular Overview
          • Cardiology Results
          • Hypertension & Blood Pressure
          • Atrial Fibrillation (AF)
          • Integrated CVD Prevention
          • Peripheral Arterial Disease (PAD)
        • SystmOne Diabetes Overview
          • SystmOne Diabetes Management
          • SystmOne Diabetes Prevention
          • SystmOne Diabetic Kidney Disease
        • ENT Infections
        • Geriatrics Overview
          • Care for Frail Patients
          • Comprehensive Geriatric Assessment
          • Co-ordinated Care
        • Haematology
        • Infection Overview
        • Learning Disabilities
        • Lifestyle
        • Lipids, Familial Hypercholesterolaemia, PCSK9i & Inclisiran Overview
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Search Guide for SystmOne
          • Lipids Protocols
          • Lipids Opt-In Resources
          • Lipid Details and Lipid Lowering Templates
          • Lipid Lowering Template
          • Lipid QoF Support
          • Screening for Familial Hypercholesterolaemia
          • Aetiology of Abnormal Lipids
          • Lipids Strategy
          • Lipids – Recommended Batch Searches
        • MSK Referral Management
        • Neurology
        • Obesity Resources
        • Ophthalmology
        • Palliative Care
        • SystmOne Renal/Urology Overview
          • Chronic Kidney Disease (CKD)
        • Respiratory Overview
          • Asthma Resources
          • Respiratory Infections
        • Rheumatology Overview
          • Bone Health
      • Women’s Health Overview
        • Gynaecology Resource Overview
          • Cervical Screening
          • Contraception
          • Prolapse
      • Vaccination Overview
        • COVID-19 Resources- SystmOne
        • Influenza Vaccination
        • Meningitis B Vaccination
        • Meningitis ACWY Vaccination
        • Pneumococcal Vaccination
        • Shingles Vaccination
  • FAQs
  • News and Events
    • Demonstrations
    • Events
      • Recordings
    • Articles
    • Conference abstracts
  • Contact us
You are here: Home / Resources / SystmOne Resource Centre / Medicine Management / Safe Prescribing of Valproate

Safe Prescribing of Valproate

The following CDRC resources are available to support safe Valproate Prescribing.

Set-up

The CDRC system allows you to manage valproate prescribing in line with the valproate prevention programme. 

You will need to add the recall type: Setup > Data Entry > Recall type 

Amend Recall Type 
Recall type name 
Shon name 
Category 
Valproate Annual Risk Acknowledgement Form 
Valporate ARAF 
Applicable genders Males Z] Females 
Minimum applicable age 
Maximum applicable age 
Defaut recall period 
Recall deadline 
Follow-up recall type 
10 
60 
years 
years 
No Deadline 
Prompt before creating follow-up 
Follow-up date is relative to last recall date 
X Valproate 
Template 
Availabilty 
Cytology smear dialog (for wating for resuts) 
Cytology resut dialogs (for scheduling next smear) 
Vaccination dialog 
Contraception dialog 
Linked Read codes 
Code 
- 
Description 
No codes selected 
Cancel
Reports

The following search, found in CDRC Quality > Drugs Requiring Monitoring, will identify all patients in the practice who appear to need an ARAF.  It would be sensible to add this search to a batch report so a task is sent at regular intervals to an individual or group at the unit. 

Valproate Template

How to Access:

In the lower left hand corner use the search bar, type in ‘Valproate’ and select the following template:

Alternatively, press F12 and search for ‘Valproate’, this will open the aforementioned template.

Valproate Template:

The Valproate template shows key information about valproate prescribing and safety. 

Valproate Scripts 
Valproate 
Monitoring Requirements 
Pre-menopausal women of child-bearing potential must have 
an Annual Risk Acknowledgement Form completed by a 
specialist each year 
This includes women who have had sterilisatiom 
MHRA Alert - Valproate in females with child-bearing potential 
Valproate Prevent Programme Resources 
Post-menopausal 
Recall -Valproate Annual Risk Acknowledgement Form 
No record that uterus is absent 
No record that this patient is post-menopausal 
16 Oct 2020 
FORBES, 
FORBES 
Valproate Annual Risk Acknowledge 
Gareth (Dr) (General Medical Practitioner) 
Pending 
12 Nov 201g11:11 
Anticonvulsants Checklist 
Show Valproate Scripts 
ORM Anticonvulsants 
Entered by 
Finished by 
Anticonwlsant Medication 
Drug name(s) 
Indication(s) at initiation 
Current supervising team 
Current indication(s) 
Date last reviewed 
Patient sex 
Child-bearing potential? 
Aware that must not get pregnant 
Gareth (Dr) (General Medical Practitioner) [12 Nov 201g 11:1 1] 
Valproate 
Epilepsy 
Epilepsy specialist nurse 
Epilepsy 
Female 
Yes 
Yes 
Will report pregnancy/contraception issues 
immediately 
Current contraception 
Aware that needs annual specialist review 
Yes 
None 
Yes 
Valproate ARAF completed by specialist in last year Yes 
Female patient has valproate PIL 
Current Consent 
Not known 
Best Interests
Valproate Valproate Scripts 
Valproate 
Monitoring Requirements 
Pre-menopausal women of child-bearing potential must have 
an Annual Risk Acknowledgement Form completed by a 
specialist each year 
This includes women who have had sterilisatiom 
MHRA Alert - Valproate in females with child-bearing potentiat 
Valproate Prevent Programme Resources 
Post-menopausal 
Recall -Valproate Annual Risk Acknowledgement Form 
CONSIDER NEED FOR VALPROATE ARAF 
No record that uterus is absent 
No record that this patient is post-menopausal 
Etonogestrel 68mg implant 
fit by gp/nurse 
17 2013 
11 May 2016 
Insertion of subcutaneous contraceptive in arm CXa850 
11 May 2016 Removal of subcutaneous contraceptive IXa85g) 
NO RECORD OF VALPROATE ANNUAL RISK ASSESSMENT FORM 
DCS Anticonvulsants Questionnaire view has no data for patient 
Anticonvulsants Checklist 
Show Valproate Scripts
Prescribing Alert

If valproate is prescribed in a woman of child bearing potential the following alert is displayed. 

Question 
Valproate Warning 
This patient appears to be a women of child-bearing potential 
Valproate should only be prescribed as pan ofthe valproate prevention programm4 
She should have an Annual Risk Assessment Form completed by a specialist (nurse or doctor) at least 
once a year 
There is no record ofa current ARAF 
La!proate

This alert will not trigger if: 

  • There is a pending ARAF Recall recorded with a date in the future 
  • The woman is recorded as post-menopausal 
  • A hysterectomy is recorded 

Practices might consider disabling the system-wide valproate alerts which are not very specific. 

Footer

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter
  • Terms of Reference
  • Ethics & Governance
  • Privacy policy
  • Terms of use
  • Join CDRC Precision

Copyright © 2023 Clinical Digital Resource Collaborative